Computational Biology Market 2023 Driving Factors Forecast Research 2029

Computational biology market is anticipated to grow at a considerable CAGR of 15.8% during the forecast period. Computational biology is the use of data analysis, mathematical modeling, and computational simulations to understand biological systems and relationships. It's an interdisciplinary field that uses computational methods to analyze large collections of biological data, such as genetic sequences, cell populations, or protein samples. Chronic diseases, such as cancer, heart disease, and diabetes, are a major global health problem. Computational biology is being used to develop new drugs and treatments for chronic diseases, as well as to improve the diagnosis and management of these diseases. This is one of the key drivers for the market growth. Computational biology tools can be used to analyze large datasets of genomic, transcriptomic, and proteomic data to identify new genes and proteins that play a role in the development and progression of chronic diseases. Once these new drug targets have been identified, researchers can begin to develop new drugs that target these molecules. Computational biology tools can be used to design new drugs that are more effective and have fewer side effects. For example, computational biology tools can be used to simulate the interaction between a drug molecule and its target protein to identify the most effective drug structure. Computational biology tools can be used to predict the toxicity and efficacy of drugs before they are tested in clinical trials. This can help to save time and money in the drug development process. Computational biology tools can be used to develop new diagnostic tests and to develop personalized treatment plans for patients with chronic diseases. For example, computational biology tools can be used to analyze the patient's genetic profile to identify the most effective and safest treatments for that particular patient.

Get Free Sample link @ https://www.omrglobal.com/request-sample/computational-biology-market

One example of how computational biology is being used to develop new drugs for chronic diseases is the development of targeted cancer therapies. Targeted cancer therapies are drugs that target specific molecules that are involved in the growth and survival of cancer cells. Computational biology tools are being used to identify new drug targets for cancer, to design new targeted cancer therapies, and to predict the efficacy of targeted cancer therapies in clinical trials. Another example of how computational biology is being used to improve the diagnosis and management of chronic diseases is the development of personalized medicine approaches for diabetes. Diabetes is a chronic disease that affects the body's ability to produce or use insulin, a hormone that regulates blood sugar levels. Computational biology tools are being used to analyze the genetic profile of patients with diabetes to identify the most effective and safest treatments for that particular patient.

full report of Computational Biology Market available @ https://www.omrglobal.com/industry-reports/computational-biology-market

• Market Coverage
• Market number available for - 2023-2029
• Base year- 2022
• Forecast period- 2023-2029
• Segment Covered- By Source, By Product Type, By Applications
• Competitive Landscape- Archer Daniels Midland Co., Ingredion Inc., Kerry Group Plc, Cargill
• Inc., and others

Market Segmentation
Global Computational Biology Market by Application
o Drug discovery and development
o Clinical trials
o Human body simulation software
o Preclinical drug development
o Others (Cellular and biological simulation)

Global Computational Biology Market by Service
o Software platforms
o Infrastructure and hardware
o Consulting services

Global Computational Biology Market by End-use
o Academia and research
o Pharmaceutical and biotechnology companies
o Clinical diagnostics companies

Regional Analysis
o North America
o United States
o Canada
o Europe
o UK
o Germany
o Italy
o Spain
o France
o Rest of Europe
o Asia-Pacific
o China
o India
o Japan
o South Korea
o Rest of Asia-Pacific
o Rest of the World

Company Profiles
o Agilent Technologies, Inc.
o Bio-Rad Laboratories, Inc.
o Certara, Inc.
o Chemical Computing Group ULC ("CCG")
o Compugen
o DNAnexus, Inc.
o DNASTAR
o Genedata
o InSilico Medicine
o Intelisys, Inc.
o Nimbus Therapeutics
o Oxford Nanopore Technologies plc
o PacBio.
o PerkinElmer U.S. LLC.
o PhenX
o Simulations Plus
o Yokogawa Insilico Biotechnology GmbH

The Report Covers
• Market value data analysis of 2022 and forecast to 2030.
• Annualized market revenues ($ million) for each market segment.
• Country-wise analysis of major geographical regions.
• Key companies operating in the global Computational biology market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
• Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
• Analysis of market-entry and market expansion strategies.
• Competitive strategies by identifying 'who-stands-where' in the market.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/computational-biology-market

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404

This release was published on openPR.